HealthEquity Ownership

HQY Stock  USD 103.57  0.19  0.18%   
The majority of HealthEquity outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in HealthEquity to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in HealthEquity. Please pay attention to any change in the institutional holdings of HealthEquity as this could imply that something significant has changed or is about to change at the company. Please note that on July 9, 2024, Representative Josh Gottheimer of US Congress acquired under $15k worth of HealthEquity's common stock.
 
Shares in Circulation  
First Issued
2013-06-30
Previous Quarter
88.3 M
Current Value
88.6 M
Avarage Shares Outstanding
67 M
Quarterly Volatility
16.5 M
 
Yuan Drop
 
Covid
Some institutional investors establish a significant position in stocks such as HealthEquity in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of HealthEquity, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Dividend Yield is likely to rise to 0.07 in 2024. Dividend Payout Ratio is likely to rise to 4.68 in 2024. Common Stock Shares Outstanding is likely to drop to about 68.4 M in 2024. Net Loss is likely to rise to about (22.4 M) in 2024.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HealthEquity. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.
For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.

HealthEquity Stock Ownership Analysis

About 98.0% of the company shares are owned by institutional investors. The book value of HealthEquity was currently reported as 24.7. The company has Price/Earnings To Growth (PEG) ratio of 1.13. HealthEquity had not issued any dividends in recent years. HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company was incorporated in 2002 and is headquartered in Draper, Utah. Healthequity operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 3688 people. To learn more about HealthEquity call Jon Kessler at 801 727 1000 or check out https://www.healthequity.com.
Besides selling stocks to institutional investors, HealthEquity also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different HealthEquity's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align HealthEquity's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

HealthEquity Quarterly Liabilities And Stockholders Equity

3.51 Billion

HealthEquity Insider Trades History

Roughly 2.0% of HealthEquity are currently held by insiders. Unlike HealthEquity's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against HealthEquity's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of HealthEquity's insider trades
 
Yuan Drop
 
Covid

HealthEquity Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as HealthEquity is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading HealthEquity backward and forwards among themselves. HealthEquity's institutional investor refers to the entity that pools money to purchase HealthEquity's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Amvescap Plc.2024-06-30
1.6 M
Jpmorgan Chase & Co2024-06-30
1.5 M
Morgan Stanley - Brokerage Accounts2024-06-30
1.3 M
Stephens Inv Mgmt Group Llc2024-09-30
1.2 M
Allspring Global Investments Holdings, Llc2024-06-30
1.1 M
Loomis, Sayles & Company Lp2024-06-30
1.1 M
Hhg Plc2024-06-30
1.1 M
Charles Schwab Investment Management Inc2024-09-30
1.1 M
Northern Trust Corp2024-09-30
M
Blackrock Inc2024-06-30
10.7 M
Vanguard Group Inc2024-09-30
8.9 M
Note, although HealthEquity's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

HealthEquity Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific HealthEquity insiders, such as employees or executives, is commonly permitted as long as it does not rely on HealthEquity's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases HealthEquity insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Stephen Neeleman over a week ago
Acquisition by Stephen Neeleman of 24188 shares of HealthEquity at 14.0 subject to Rule 16b-3
 
Selander Robert W over a month ago
Disposition of 7500 shares by Selander Robert W of HealthEquity at 21.27 subject to Rule 16b-3
 
Corvino Frank over a month ago
Disposition of 1247 shares by Corvino Frank of HealthEquity at 80.2645 subject to Rule 16b-3
 
Jon Kessler over two months ago
Disposition of 1511 shares by Jon Kessler of HealthEquity at 78.9334 subject to Rule 16b-3
 
Elimelech Rosner over two months ago
Disposition of 12296 shares by Elimelech Rosner of HealthEquity at 77.0242 subject to Rule 16b-3
 
Elimelech Rosner over two months ago
Disposition of 1727 shares by Elimelech Rosner of HealthEquity at 83.6769 subject to Rule 16b-3
 
Elimelech Rosner over two months ago
Disposition of 12296 shares by Elimelech Rosner of HealthEquity at 77.0242 subject to Rule 16b-3
 
Corvino Frank over three months ago
Disposition of 6482 shares by Corvino Frank of HealthEquity at 21.27 subject to Rule 16b-3
 
Dillon Adrian T over three months ago
Acquisition by Dillon Adrian T of 2543 shares of HealthEquity subject to Rule 16b-3
 
Jon Kessler over three months ago
Disposition of 2781 shares by Jon Kessler of HealthEquity at 83.0782 subject to Rule 16b-3
 
Jon Kessler over three months ago
Disposition of 2199 shares by Jon Kessler of HealthEquity at 83.6511 subject to Rule 16b-3
 
Jon Kessler over six months ago
Disposition of 6279 shares by Jon Kessler of HealthEquity at 74.2552 subject to Rule 16b-3

HealthEquity's latest congressional trading

Congressional trading in companies like HealthEquity, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in HealthEquity by those in governmental positions are based on the same information available to the general public.
2024-07-09Representative Josh GottheimerAcquired Under $15KVerify

HealthEquity Outstanding Bonds

HealthEquity issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. HealthEquity uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most HealthEquity bonds can be classified according to their maturity, which is the date when HealthEquity has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

HealthEquity Corporate Filings

8K
12th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
8th of November 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
ASR
6th of September 2024
Automatic Shelf Registration Statement under Rule 415 filed with the U.S. Securities and Exchange Commission (SEC)
ViewVerify
5th of July 2024
Other Reports
ViewVerify

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for HealthEquity Stock Analysis

When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.